Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Controlled, Double-Blind, Randomized Multicentric Study On The Efficacy And Safety Of An Early Target Controlled Plasma Volume Replacement Therapy With A Balanced Gelatine Solution vs A Balanced Electrolyte Solution In Patients With Severe Sepsis

NCT02715466 is registered in ClinicalTrials.gov with B. Braun Melsungen AG as lead sponsor.

NCT NCT02715466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02715466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Controlled, Double-Blind, Randomized Multicentric Study On The Efficacy And Safety Of An Early Target Controlled Plasma Volume Replacement Therapy With A Balanced Gelatine Solution vs A Balanced Electrolyte Solution In Patients With Severe Sepsis
Lead sponsor
B. Braun Melsungen AG
Phase
Phase 4
Overall status
Terminated
Start date
April 30, 2016
Completion date
December 8, 2021
Enrollment
167 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

hypovolemia